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… the real need (in global health) is to close the data gaps, especially in low and middle-income 
countries, so that we no longer have to rely heavily on statistical modeling for data on disease burden. 
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Despite the existence of multiple validated risk-assessment and quality benchmarking tools in 
surgery, their utility outside of High Income Countries is limited. We sought to derive, validate and 
apply a scoring system that is both 1) feasible, and 2) reliably predicts mortality in a Middle Income 
Country (MIC) context. 
Methods  
A 5-step methodology was used: 
1. Development of a de novo surgical outcomes database modeled around the American College of 
Surgeons’ National Surgical Quality Improvement Program (ACS-NSQIP) in South Africa (SA 
Dataset) 
2. Use of the resultant data to identify all predictors of in-hospital death with more than 90% 
capture indicating feasibility of collection 
3. Use these predictors to derive and validate an integer-based score that reliably predicts in-
hospital death in the 2012 ACS-NSQIP  
4. Apply the score in the original SA dataset and demonstrate it’s performance  
5. Identify threshold cutoffs of the score to prompt action and drive quality improvement. 
Results 
Following Step one-three above, the 13 point Codman’s score was derived and validated on 211,737 
and 109,079 patients, respectively, and includes: 1) age≥65 (1), partially or completely dependent 
functional status (1), preoperative transfusions≥4 units (1), emergency operation (2), sepsis or septic 
shock (2) American Society of Anesthesia (ASA) score ≥3 (3) and operative procedure (1-3).  
Application of the score to 373 patients in the SA dataset showed good discrimination and calibration to 
predict an in-hospital death. A Codman Score of 8 is an optimal cutoff point for defining expected and 
unexpected deaths. 
Conclusion 
We have designed a novel risk prediction score specific for a MIC context. The Codman Score 
can prove useful for both 1) preoperative decision-making and 2) benchmarking the quality of surgical 
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A handful of landmark studies in the emerging field of surgical outcomes research have shown 
that there are significant variations in mortality following surgery between countries (1-3). National and 
international strategies to improve perioperative outcomes are urgently needed but reliable surgical 
outcomes data are lacking in the areas of the world with the highest surgical burden, greatest unmet need 
and likely the greatest variation in surgical outcomes (4).  
 
To date in the United States, the American College of Surgeons National Surgical Quality 
Improvement Program (ACS-NSQIP) remains the most robust risk-adjusted and reliable tool available 
and, most important, the only tool that is readily accepted by most surgeons (5). The ACS-NSQIP has 
been shown to reduce both morbidity and mortality in enrolled hospitals with initially worse performing 
hospitals having a greater likelihood of improvement  (6,7). A significant problem with the ACS-NSQIP 
is that its expense limits the number of participating hospitals and excludes most smaller and rural 
hospitals in the United States- hospitals about which one might legitimately wish to ask certain quality 
and safety questions  (5). Additionally, the program requires the retrospective collection of over 130 
variables per patient further limiting the generalizability of the ACS-NSQIP. For these reasons, in it’s 
current format, such a program has limited applicability in a MIC. 
 
Despite the existence of multiple validated risk-assessment and quality benchmarking tools in 
surgery, their utility in low resource settings is often limited. We still lack a clinically meaningful 
objective metric that can be applied preoperatively to a general surgery cohort in a MIC context. The 
Surgical Apgar Score has been well validated globally but is based on data collected intra-operatively at 
5-minute intervals, limiting its preoperative application  (8).   
 
Ernest Amory Codman was a courageous early 20th century champion for an “end results 
system” to track hospital outcomes and compare them between providers (9). Acknowledging the 
current global variation in patient outcomes following noncardiac surgery and the lack of meaningful 
objective metrics that reliably predict adverse events in more resource-limited settings, were the main 
drivers behind developing the Codman Score. Our primary aim was to develop a simple index with 





There were five distinct steps in this study, as summarized in Figure 1. 
 
Step 1: Development of a SA dataset 
 
Groote Schuur Hospital (GSH) is a government-funded, tertiary teaching hospital situated in 
Cape Town, South Africa. It is the chief academic hospital of the University of Cape Town and the 
referral hospital for three secondary level surgical departments in the Western Cape Metropolitan. GSH 
has a bed capacity for 1000 patients and an estimated 10,000 operations are performed annually at GSH, 
the risk-adjusted outcomes of which are not formally audited or known. The patient population was 
defined by a systematic sample of major vascular and general surgery operations performed at GSH on 
adult patients that met inclusion criteria for the ACS-NSQIP Essentials Program.  The details of this 
program have been well validated and published previously and the datasheet for this program has been 
included in the Appendix. Local adaptations are included in this text. The Departments of Surgery and 
Quality Assurance at GSH employed a clinical auditor for this study. A pilot period of one month was 
performed by the clinical auditor under direct supervision of the principle investigators where the main 
focus was on data variable definitions and to identify and solve any logistical issues of case 
identification and data capture. After the 1-month pilot period, the clinical reviewer functioned 
independently for the 3-month recruitment period from 1st April to 30th June 2014. 
Consecutive patients for inclusion were identified from the main theatre register that captures all 
operative activity in the hospital. Patients were then followed-up in the ward post-operatively where the 
data extraction occurred. A data collection sheet for this purpose was downloaded from the ACS 
website. After the one-month pilot, the datasheet was modified to increase local relevance for categories 
describing race, ethnicity, and preferred language. An online dataset with the final variables for 
inclusion was designed using REDCap (10). An iPad was given to the clinical reviewer so data 
extraction could occur directly at the bedside into the REDCap database. Once entered in the database, a 
30-day follow-up from date of surgery by telephonic interview and chart review then took place. 
Primary outcome for the simple scoring system was in-hospital death. The secondary outcome was any 
morbidity at 30-days (including in-hospital death).  This was defined by an occurrence of one of the 
specific postoperative complications spanning each of the organ systems defined in the ACS-NSQIP 
protocol.  
Step 2: Identification of predictors 
To ensure that the resultant scoring system would be feasible to apply, step two involved 
identifying only preoperative data variables collected in the SA dataset that were greater than 90% 
complete. The univariate association between these  predictors and in-hospital death in the SA dataset 
was tested with significance set at p=0.1 to err on the side of model inclusion. Step two therefore 
involved identifying variables in the SA dataset that were both 1) feasible to collect and 2) potentially 
associated with in-hospital death.  
Step3: Derivation and validation of a simple scoring index 
 
The 2012 sample of 320,816 patients from the ACS-NSQIP essentials program was used to 
derive and validate the simple scoring system. This dataset was chosen, and the methodology of data 
acquisition was replicated in South Africa, due to the breadth of preoperative variables collected for 
each patient to enhance the exploratory nature of this study and increase the generalizability of the 
derived scoring system. Two thirds of the cohort were randomly assigned to the derivation cohort 
(n=211,737) and one third was to the validation cohort (n=109,079). Operative categories were defined 
by CPT code according to a classification system previously described in the Patient Safety in Surgery 
Study  (11). Potentially significant predictors identified in the SA dataset (in step 2) were then 
dichotomised to further simplify the resultant score at thresholds cited in the literature. These binary 
predictors were entered into a logistic regression analysis in the derivation dataset using a manual 
stepwise forward selection algorithm by a process described by Anderson et al (12). An a priori decision 
was made to include procedure category as the first variable in the model. The first step was to perform 
simple logistic regression and identify the binary predictor to add to the procedure category model with 
the highest discriminatory ability to predict in-hospital death as assessed by the area under the receiver-
operator characteristic curve (ROC curve). The ROC curve is used to define the c-statistic, a 
discriminative measure to identify how well a model separates two groups (i.e. in this case, patients who 
did and did not die in hospital) (13). For each additional step, remaining variables were individually 
added to the algorithm and the resultant model combination with the highest c-statistic would progress 
to the next step until further variable addition resulted in minimal gain in discriminatory ability. The 
beta coefficients of the final binary predictors and the individual operative categories were then divided 
and rounded to the nearest integer to create a scoring system  (14). Logistic regression was then repeated 
using this single score to predict in-hospital death and any morbidity at 30 days in the validation dataset. 
The ROC curves of the score derived in the derivation and validation datasets were compared. A 
probability of in-hospital death and any morbidity was then generated for each value of the validated 
Codman Score.  
Step 4: Application of the Codman Score  
 
The validated scoring rubric was then applied to the SA dataset. The performance of the Codman 
Score was assessed by both its discriminatory ability as well as its ability to calibrate in-hospital deaths 
and any morbidity. Measure of calibration of the Codman Score was assessed by the Hosmer and 
Lemeshow goodness-of-fit statistic (GOF)  (13). 
Step 5: Identify threshold cutoffs of the score to prompt action and drive quality improvement 
A threshold score was identified in the ACS-NSQIP database with the highest sensitivity and 
specificity to identify an in-hospital death. This was identified using the Youden index (ie. J-statistic), a 
statistical tool that defines the optimal cuttoff point (C*) for the differentiating ability of a test using 
sensitivity and specificity of that test  (15). This C* was applied to the SA dataset to objectively classify 
patients into four categories; expected successes, unexpected failures, unexpected successes and 
expected failures.  
Ethics was granted by the University of Cape Town’s research ethics committee. All analyses 
were performed using STATA 14. 
 
RESULTS 
A total of 373 patients were included in the SA dataset. The mean age of the cohort was 49.9 
years (range 13 – 91), 57.3% were female, 20.3% were vascular patients and 79.6% were general 
surgery patients. The patients in the two datasets were not similar as demonstrated by the comparison in 
Table 1 based on the preoperative predictors that were greater than 90% complete in the SA dataset. 
There was a greater proportion of patients classed as an ASA greater or equal to 3 in the ACS-NSQIP 
dataset. Patients in the SA dataset had a higher proportion of emergency cases, diabetics, symptomatic 
dyspnea, functional dependency, congestive heart failure, chronic obstructive pulmonary disease, acute 
renal failure, disseminated cancer and preoperative sepsis. Higher rates of vascular and endocrine 
surgery was performed in the SA dataset, whereas, higher rates of hernia, thoracic and lymphatic surgery 
were performed in the ACS-NSQIP. 
 
The occurrence of endpoints, including outcomes for prediction, in both the ACS-NSQIP and SA 
datasets are presented in Table 2. The SA dataset had a significantly higher proportion of all outcome 
measures except for CNS occurrences. The unadjusted in-hospital mortality rate was 6.4% (95% CI 4.34 
– 9.44) and 30-day any complication rate was 34.1% (95% CI 29.73 – 40.26) in the SA dataset.  In the 
ACS-NSQIP dataset the unadjusted in-hospital mortality rate was 1.1% (95%CI 1.04 – 1.11) and 30-day 
any complication rate was 13.8% (95% CI 13.68 – 13.92). 
 
The final multivariate model from the derivation dataset is presented in Table 3. The binary 
predictors are presented in order of entry into the model along with the c-statistics derived after addition. 
The resultant Codman Score relies on seven simple preoperative variables; the American Society of 
Anesthesia (ASA) score, emergency status, the amount of packed red blood cells transfused within 72 
hours prior to surgery, age, sepsis status, functional dependency status and surgical procedure. The total 
Codman Score ranges from 0 to 13, with higher scores indicating patients at higher risk of in-hospital 
death. The scoring rubric for the Codman Score is presented in Table 4. 
 
There was no difference in the discriminatory ability of the score in the derivation and validation 
datasets (p=0.16) as seen by the ROC curve comparison in figure 2. When applied to the whole ACS-
NSQIP, there was a stepwise increase in both in-hospital mortality and any morbidity at 30 days as seen 
in figure 3. When applied to the SA dataset, 351 patients (94.1%) had all the data variables complete to 
compute a Codman Score of which the median score was 4 (IQR 3-6). The score had a c-statistic of 
0.8672 (95% CI 0.8136 – 0.9209) and GOF statistic of 1.11 (p = 0.292) to predict an in-hospital death 
and a c-statistic of 0.7183 (95% CI 0.6496 – 0.7870) and GOF statistic of 0.04 (p = 0.848) to predict any 
complication at 30 days. In the ACS-NSQIP a C* of 8 was identified as the optimum threshold with the 
highest sensitivity (88.76%) and specificity (80.63%) to preoperatively identify an in-hospital death. 
Applied to the SA dataset, the C* identified 8 unexpected deaths, 30 unexpected survivors, 14 expected 
deaths and 300 expected survivors. 
 
DISCUSSION 
This study describes the derivation, validation and demonstrated utility of a simple 7-variable 
index, the Codman Score, designed to preoperatively identify adult general or vascular surgery patients 
at risk for in-hospital death in a MIC context.  
 
Developed to ensure feasibility of data capture, the score can be used for preoperative planning 
as well as an objective surgical quality metric. This algorithm has been derived and validated on the 
ACS-NSQIP essentials dataset.  Therefore, using the expected probabilities of mortality and morbidity 
for each score (0-13), surgical units around the world can use the simple and parsimonious Codman 
Score for global benchmarking of risk-adjusted outcomes against the ACS-NSQIP consortium by an 
objective “observed versus expected” quality metric (O/E). 
Previous work has supported the fact that a model based on only a few variables may provide 
enough discrimination to measure surgical outcomes in a risk-adjusted manner. Rubinfeld et al found the 
c-statistic for mortality decreased only slightly from 0.907 using all variables to 0.902 using 10 variables 
and argue that only a few variables are required for predictive accuracy (16). Dimick et al found that 
limited models based on 5 or 12 variables had comparable discrimination to a 21-variable model (17). 
Birkmeyer et al also found high correlation between a 5-variable and a 20-variable morbidity risk model 
and recommended that the new version of the NSQIP have no more than 5 to 10 core covariates (12). 
Anderson et al provide several examples of risk-adjustment models that may be appropriate for hospitals 
in resource-limited settings. Their 6-variable model with the highest discriminatory ability included 
ASA class, age, sepsis, functional status, cancer and emergency status (12). Our work has reproduced 
similar findings but has further consolidated the model into a pragmatic index, which also includes a 
procedure variable, simultaneously provides a preoperative risk prediction tool and has been validated 
outside the ACS NSQIP.  
 
Clinical outcomes following major surgery are poorly described at a national level and even an 
institutional level in MIC’s (4). Furthermore, by only reporting unadjusted postoperative mortality rate 
(POMR), as suggested by the Lancet Commission on Global Surgery, hospitals that manage sicker 
patients would appear to have worse outcomes (18). A more meaningful quality metric is needed. Such a 
metric for measuring quality is the observed versus expected (O/E) ratio. The O/E ratio is a measure of 
the degree of agreement between the predicted outcome (E) and the actual outcome (O) (18). With these 
data, meaningful comparison of risk-adjusted outcomes between surgical units can be achieved. 
Nevertheless, the adoption of the O/E ratio as a metric for surgical quality has been limited, mostly 
because the measurement of the ‘E’ in the O/E ratio has remained a challenge for surgical units outside 
quality consortia like the ACS-NSQIP. However, based on seven easily attainable preoperative 
variables, the Codman Score generates an expected individual probability for both mortality and 
morbidity.  
 
 The major limitation of this study is the small, single-centered SA dataset. Applying the ACS-
NSQIP essentials methodology for a longer time was not feasible and would have threatened the 
accuracy of the dataset.  Data quality was chosen over quantity for this study. One of the most accepted 
predictors of a poor outcome is a high ASA class, which is subject to inter-rater reliability  (20). A study 
by Cohen ME et al. explored the effect of subjective preoperative variables on risk-adjusted assessment 
of hospital morbidity and mortality  (21). Using ASA and functional health status, the authors showed 
that these variables have unique contributions risk-adjustment models and have little indication that they 
are subject to an important level of institutional bias. They therefore concluded that it is appropriate that 
they be used to assess risk-adjusted surgical quality  (21). The inclusion of the blood transfusion 
requirement of 4 units or greater in the score may exclude the applicability of the Codman Score for 
resource limited settings where blood transfusion is not an option. Our model building process ranked 
this variable as the third most discriminatory after ASA and emergency status. The work by Anderson et 
al proposes the use of haematocrit as an alternative but this too may not be a practical to collect (12). 
The Lancet Commission included a safe and affordable blood supply as one of the ten essential needs 
for the provision of safe surgical and anaesthesia and if a surgical collaborative is interested in auditing 
their outcomes, access to a safe blood supply must be a priority step towards quality improvement. This 
is a model, which may be feasible in a low income country (LIC) or may require further modifications. 
It is necessary however, that there is external validation of the model in a LIC. Furthermore, to extend 
the model beyond general and vascular surgery, it will need possible inclusion of other surgical 
procedures into the model.  
 
We believe this study provides evidence supporting the use of the Codman Score and justifies a 
prospective interrogation of its accuracy and generalizability. The Codman Score is easily calculated, 
predictive and discriminative for major complications among adults undergoing in-patient, general 
surgery operative procedures. Its application has the potential to advance surgical quality improvement 
initiatives in MIC’s. 
 
REFERENCES 
 (1) Haider AH, Hashmi ZG, Gupta S, Zafar SN, David JS, Efron DT, et al. Benchmarking of trauma 
care worldwide: the potential value of an International Trauma Data Bank (ITDB). World J Surg 2014 
Aug;38(8):1882-1891. 
(2) Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after surgery in 
Europe: a 7 day cohort study. Lancet 2012 Sep 22;380(9847):1059-1065. 
(3) Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, et al. A surgical safety 
checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009 Jan 
29;360(5):491-499. 
(4) Meara JG, Greenberg SL. Global surgery as an equal partner in health: no longer the neglected 
stepchild. Lancet Glob Health 2015 Apr 27;3 Suppl 2:S1-2. 
(5) Farmer DL. NSQIP lite: a potential tool for global comparative effectiveness evaluations. Arch Surg 
2012 Sep;147(9):803-804. 
(6) Hall BL, Hamilton BH, Richards K, Bilimoria KY, Cohen ME, Ko CY. Does surgical quality 
improve in the American College of Surgeons National Surgical Quality Improvement Program: an 
evaluation of all participating hospitals. Ann Surg 2009 Sep;250(3):363-376. 
(7) Cohen ME, Liu Y, Ko CY, Hall BL. Improved Surgical Outcomes for ACS NSQIP Hospitals Over 
Time: Evaluation of Hospital Cohorts With up to 8 Years of Participation. Ann Surg 2015 Feb 26. 
(8) Haynes AB, Regenbogen SE, Weiser TG, Lipsitz SR, Dziekan G, Berry WR, et al. Surgical outcome 
measurement for a global patient population: validation of the Surgical Apgar Score in 8 countries. 
Surgery 2011 Apr;149(4):519-524. 
(9) Berwick DM. Measuring surgical outcomes for improvement: was Codman wrong? JAMA 2015 Feb 
3;313(5):469-470. 
(10) Project REDCap. 2015; Available at: http://www.project-redcap.org/. Accessed June, 24, 2015. 
(11) Johnson RG, Arozullah AM, Neumayer L, Henderson WG, Hosokawa P, Khuri SF. Multivariable 
predictors of postoperative respiratory failure after general and vascular surgery: results from the patient 
safety in surgery study. J Am Coll Surg 2007 Jun;204(6):1188-1198. 
(12) Andersen J, Lassiter R, Bickler S, Talamini M, Chang D. Brief tool to measure risk-adjusted 
surgical outcomes in resource-limited hospitals. Arch Surg 2012;147(9):798-803. 
(13) Cook F. Analytical epidemiology lecture series. Harvard TH Chan School of Public Health, 
Program in Clinical Effectiveness: https://www.hsph.harvard.edu/clinical-effectiveness/2014. 
(14) Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation 
and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. 
Circulation 1999 Sep 7;100(10):1043-1049. 
(15) Batterton KA, Schubert CM. A nonparametric fiducial interval for the Youden index in multi-state 
diagnostic settings. Stat Med 2015 Aug 16. 
(16) Rubinfeld I, Farooq M, Velanovich V, Syed Z. Predicting surgical risk: how much data is 
enough? AMIA Annu Symp Proc. 2010;2010:777–781. 
 
(17) Dimick JB, Osborne NH, Hall BL, Ko CY, Birkmeyer JD. Risk adjustment for comparing hospital 
quality with surgery: how many variables are needed? J Am Coll Surg.2010;210(4):503–508.  
(18) Ariyaratnam R, Palmqvist CL, Hider P, Laing GL, Stupart D, Wilson L, et al. Toward a standard 
approach to measurement and reporting of perioperative mortality rate as a global indicator for surgery. 
Surgery 2015 Jul;158(1):17-26. 
(19) Henderson WG, Daley J. Design and statistical methodology of the National Surgical Quality 
Improvement Program: why is it what it is? Am J Surg 2009 Nov;198(5 Suppl):S19-27. 
(20) Haynes SR, Lawler PG. An assessment of the consistency of ASA physical status classification 
allocation. Anaesthesia 1995 Mar;50(3):195-199. 
(21) Cohen ME, Bilimoria KY, Ko CY, Richards K, Hall BL. Effect of subjective preoperative variables 








Table 1. Comparison of the preoperative risk characteristics in the ACS-NSQIP and SA datasets 






Odds ratio for in-hospital death 
and 95% CI’s in the SA dataset 
Age category ≥65 143,212 
(44.64) 
80 (21.45) 0.932 (0.788 - 1.103) 
Male gender 140,917 
(43.92) 
159 (42.63) 2.231 (1.299 - 3.833) 
Non-white race 79,565 (24.80) 331 (88.74) 0.941 (0.682 - 1.298) 
Emergency case 45,585 (14.21) 137 (36.73) 5.333 (2.994 - 9.501) 
ASA ≥ 3* 152,739 
(47.78) 
103 (33.76) 2.551 (1.468 - 4.433) 
Speciality vascular 42,900 (13.37) 76 (20.38) 0.971 (0.502 - 1.877) 
Diabetic  52,676 (16.42) 79 (21.18) 1.017 (0.526 - 1.953) 
Smoking within the year 61,373 (19.13) 193 (51.74) 1.043 (0.588 - 1.849) 
Dyspnoea ≥ moderate exertion 23,098 (7.20) 126 (36.63) 2.689 (1.523 - 4.749) 
Functional status ≥ partially dependent 9,700 (3.02) 55 (14.75) 2.705 (1.401 - 5.227) 
Ventilator dependent w/in 48hrs 1,673 (0.52) 2 (0.54) 4.016 (0.248 - 65.108) 
Chronic Obstructive Pulmonary Disease 15,845 (4.94) 24 (6.43) 3.306 (1.326 - 8.239) 
Congestive Heart Failure 2,640 (0.82) 8 (2.14) 7.069 (1.642 - 30.429) 
Hypertension 148,458 
(46.28) 
134 (38.29) 0.802  (0.448 - 1.436) 
Acute Renal Failure 1,663 (0.52) 16 (4.29) 4.872 (1.697 - 13.987) 
Dialysis 6,525 (2.03) 6 (1.61) 6.098 (0.997 - 37.301) 
Cancer 7,364 (2.30) 23 (6.17) 2.652 (1.048 - 6.709) 
Open wound 13,671 (4.26) 37 (9.92) 2.001 (0.922 - 4.341) 
Long term steroid use 12,275 (3.83) 12 (3.22) 1.352 (0.045 - 2.778) 
>10% weight loss 5,837 (1.82) 25 (6.70) 1.721 (0.681 - 4.349) 
Preoperative blood transfusion ≥4 packed 
cells in 72 hours 
4,456 (1.39) 9 (2.41) 8.702 (2.113 - 35.838) 
Septic status ≥ sepsis 11,524 (3.59) 55 (15.67) 4.811 (2.505 - 9.239) 













1. Integumentary and Musculoskeletal: 





2. Vascular A:  
Thoracic and thoracoabdominal 
aneurysms, embolectomy/thrombectomy, 
venous reconstruction, and endovascular 
repair (33001-34900) 
2, 777 (0.87) 31 (8.31) 
3. Vascular B: 
Aneurysm, blood vessel repair, 
thromboendarterectomy, angioscopy, 
angioplasty and atherectomy, bypass and 
6, 591 (2.05) 30 (8.04) 
composite grafts, other artery, and vein 
(35001-37799) 
2.022 (1.799 – 2.336) 
4. Thoracic and lymphatic: 
Respiratory system, hemic and lymphatic 





5. Upper Gastrointestinal: 
Mouth, palate, salivary glands, pharynx, 
adenoids, and esophagus (40000-43499) 
5, 317 (1.66) 5 (1.34) 
6. Mid and lower Gastrointestinal: 
Stomach, intestines, appendix and 
mesentery, rectum and anus, liver, biliary 
tract, pancreas, abdomen, peritoneum, 





7. Hernia surgery: 






Endocrine system (60000-60999) 

























 N              % 
P-value 
Wound 15,520  4.84 27 7.24 <0.05 
Respiratory 10,061 3.14 19 5.09 <0.05 
Urinary tract 6,643 2.07 21 5.63 <0.05 
CNS 749 0.23 1 0.27 NS 
Cardiac 2,492 0.23 9 2.41 <0.05 
Other  27,371 8.53 50 13.40 <0.05 
Outcomes for 
prediction 
    
Any morbidity 
at 30 days 




















Table 3. The multivariate model used to derive the Codman Score  




P-Value ROC of model after 
variable addition 
Endocrine  Reference 







Integumentary and Musculoskeletal  1.738 <0.01 
Thoracic and Lymphatic 2.403 <0.0001 




Mid and Lower Gastrointestinal 2.424 <0.0001 
Vascular A 2.934 <0.0001 
Vascular B 2.769 <0.0001 
Binary predictor 
ASA ≥ 3 2.849 <0.0001 0.8053 
Emergency case 1.513 <0.0001 0.8751 
Preoperative blood transfusion ≥4 




Age category ≥65 years 0.958 <0.0001 0.9009 
Septic status ≥ sepsis 1.562 <0.0001 0.9079 
Functional status ≥ partially dependent 0.921 <0.0001 0.9152 











Table 4 Components of the Codman Score 











Functional dependency status 
Independent 








Preoperative blood transfusion within 72 hours of surgery 
Less than 4 packed red blood cells 













Preoperative sepsis status 
 
None or SIRS* 








Less than 3 






































SIRS* Systemic Inflammatory Response Syndrome 
FIGURES 
 




ACS-NSQIP* American College of Surgeons National Surgical Quality Improvement Program 











Development of a de novo 
database modeled around the 
ACS-NSQIP* (SA #Dataset) 
Use the SA dataset to identify all 
predictors of in hospital death with 
more than 90% capture
Use these predictors to derive and 
validate an integer based score in 
the 2012 ACS-NSQIP* dataset
Apply the validated score to the 
original  SA# dataset and 
demonstrate performance
Identify threshold cutoffs of the 
score to prompt action and drive 
quality improvement
Figure 2. Comparison of the discriminatory ability to predict an in-hospital death in the ACS-NSQIP 
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1-Specificity
Derivation ROC area: 0.908 Validation ROC area: 0.901
Reference














1 2 3 4 5 6 7 8 9 10 11 12 13
Mortality rate (%) 0.01 0.03 0.11 0.18 0.33 1.3 2.5 7.3 12.2 22.8 32.4 51 66.67
Morbidity rate (%) 1.8 5.8 6.5 9.5 14.3 22.2 29.3 43.5 59.9 69.1 82.1 85 100
Cummalitive total SA dataset 














AMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT 
PROGRAM ESSENTIALS WORKSHEET 
 *IDN _________________________  Cycle Number ____________________ 
 LMRN________________________  Case Number ____________________ 
DEMOGRAPHICS 
Last Name: _____________________________________________________First: __________________________________________MI: ______ 
Street Address: __________________________________________________________________________________________________________ 
City/Town: __________________________________________ State/Province: __________ Zip: ____________ Country: _____________ 
Home Phone (_____) ______________Work Phone (_____) _______________ Cell Phone (_____) _______________ 
*DOB: _______/_______/________ (mm/dd/yyyy) Gender: å¨ Male å¨ Female 
Race: å¨ White å¨ American Indian / Alaska Native å¨ Asian 
å¨ Black / African American å¨ Native Hawaiian / Other Pacific Islander å¨ Unknown 
Ethnicity: Hispanic - å¨ YES å¨ NO Preferred Language: å¨ ENGLISH å¨ SPANISH 
SURGICAL PROFILE 
Principal Procedure ___________________________________________________________________________ CPT Code _________________________ 
Patient Status: å¨ Inpatient å¨Outpatient Elective Surgery: å¨ YES å¨ NO å¨ Unknown 
Transfer / Origin Status: 
å¨ Not transferred, admitted directly from home å¨ Transfer from other (i.e. Spinal Cord Injury Unit or 
other facility not listed) 
å¨ Acute Care Hospital (inpatient status only) å¨ Transfer from outside Emergency Department 
å¨ Nursing Home/Chronic Care Facility/Intermediate Care Unit 
å¨ Unknown (if transferred from unknown location or Facility) 











*Surgical Specialty: (select one) 
1. General Surgery 3. Thoracic 5. Orthopedics 7. Urology 9. Plastics 
2. Vascular 4. Cardiac 6. Neurosurgery 8. Otolaryngology (ENT) 10. Gynecology 
Attending Surgeon’s Name: _____________________________________________ Attending Surgeon’s IDN: ___________________ 
LCN: _________________________________________________________________ Encounter Number: ________________________ 
Revision: January 1, 2011 - 2 - ACS NSQIP ESSENTIALS 
PREOPERATIVE RISK ASSESSMENT 
GENERAL RENAL 
Height _______ Inches CM Acute Renal Failure w/in 24 hrs YES NO 
Weight _______ Pounds KG Currently requiring or on Dialysis w/in 2 wks YES NO 
Diabetes Mellitus Non- 
Insulin Insulin NO NUTRITIONAL/IMMUNE/OTHER 
Current Smoker w/in 1 year YES NO Disseminated Cancer YES NO 
Dyspnea Mod. 
Exertion At Rest NONE Open Wound (w/ or w/out infection) YES NO 
Functional Health Status prior to 
surgery I___ PD ____ TD ___ Unk ___ Steroid use for chronic condition YES NO 
PULMONARY >10% loss of body wt. last 6 months YES NO 
Vent. Dependent w/in 48 hrs YES NO Bleeding disorders YES NO 
COPD (severe) YES NO Preop Transfusions (RBC units w/in 72 hrs) YES NO 
HEPATOBILIARY Sepsis w/in 48 hours SIRS NO 
Ascites w/in 30 days YES NO Sepsis 
CARDIAC Sep Shock 
CHF w/in 30 days YES NO 
Hypertension req. meds. YES NO 
LABORATORY DATA 
LABORATORY DATA: (report preop lab values closest to the Procedure/Surgery start date & time) 
Preop values should be within 90 days prior to surgery 
PREOPERATIVE LAB DATA Value 90 days unknown Date 
Serum Sodium (Na) å¨ 
____/____/____ 
Blood Urea Nitrogen (BUN) å¨ 
____/____/____ 
Creatinine (Cr) å¨ 
____/____/____ 
Albumin (ALB) å¨ 
____/____/____ 
Total Bilirubin (TB) å¨ 
____/____/____ 
Serum Glutamic-Oxaloacetic Transaminase (SGOT)/(AST) å¨ 
____/____/____ 
Alkaline Phosphatase (Alk Phos) å¨ 
____/____/____ 
White Blood Count (WBC) å¨ 
____/____/____ 
Hematocrit (Hct) å¨ 
____/____/____ 
Platelets (Plt) å¨ 
____/____/____ 
Prothrombin Time (PT) å¨ 
____/____/____ 
Internat’l Normalized Ratio (INR) å¨ 
____/____/____ 
OPERATIVE INFORMATION 
Emergency Case: å¨ YES å¨ NO 
Wound Classification: å¨Clean å¨ Clean/Contaminated å¨ Contaminated å¨ Dirty/Infected 
ASA Class (circle one): 1 2 3 4 5 6 None Assigned (for local anes. only) 
OPERATIVE TIMES: Procedure / Surgery Start: _______:_______ Procedure/Surgery Finish: _______:_______ 
Revision: January 1, 2011 - 3 - ACS NSQIP ESSENTIALS 
ADDITIONAL OPERATIVE PROCEDURES 
OCCURRENCES 
POSTOPERATIVE OCCURRENCES: å¨ YES å¨ NO 
(Although not required for this program, you may wish to document ‘treatment’ and ‘outcome to date’ of the occurrence for internal quality 
monitoring) 
Date Treatments / Outcomes / Comments 
Wound Occurrences 
Superficial Incisional SSI ______/______/_____ _________________________________________ 
Present at Time of Surgery? å¨ YES å¨ NO 
Deep Incisional SSI ______/______/_____ _________________________________________ 
Present at Time of Surgery? å¨ YES å¨ NO 
Organ/Space SSI ______/_____/______ _________________________________________ 
Present at Time of Surgery? å¨ YES å¨ NO 
Wound Disruption ______/_____/______ _________________________________________ 
Respiratory Occurrences 
Pneumonia (PNA) ______/_____/______ _________________________________________ 
Present at Time of Surgery? å¨ YES å¨ NO 
Unplanned Intubation _____/______/______ _________________________________________ 
Pulmonary Embolism _____/______/______ _________________________________________ 
On ventilator > 48 hours _____/______/______ _________________________________________ 
Present at Time of Surgery? å¨ YES å¨ NO 
Urinary Tract Occurrences 
Progressive Renal Insufficiency _____/_____/______ _________________________________________ 
Acute Renal Failure _____/_____/______ _________________________________________ 
Urinary Tract Infection (UTI) _____/_____/______ _________________________________________ 
Present at Time of Surgery? å¨ YES å¨ NO 
CNS Occurrences 
Stroke / CVA _____/_____/_____ _________________________________________ 
Cardiac Occurrences 
Cardiac Arrest req. CPR _____/_____/_____ _________________________________________ 
Myocardial Infarction _____/_____/_____ _________________________________________ 
Other Occurrences 
Bleeding Requiring Transfusion (72h of surgery start time) 
(transfusion of 1-200 units) _____/_____/_____ # of units transfused: ______________________ 
Deep Vein Thrombosis (DVT) req. Therapy _____/_____/_____ __________________________________________ 
Sepsis: Sepsis _____/_____/_____ __________________________________________ 
Septic Shock _____/_____/_____ __________________________________________ 
Other Postoperative Occurrences (ICD-9 code): _____/_____/_____ (ICD-9 code) _______________________________ 
HOSPITAL DISCHARGE INFORMATION / READMISSIONS / MORTALITY / REOPERATIONS 
Discharge Destination: 
å¨ Chronic Care Facility, not Home å¨ Home å¨ Expired 
å¨ Unskilled Facility, not Home å¨ Separate Acute care (transferred to another acute care facility) å¨ Unknown 
å¨ Facility which was Home å¨ Rehab 
Post-op ICD.9 Code _________________________ Diagnosis: _____________________________________________________________________ 
















Revision: January 1, 2011 - 4 - ACS NSQIP ESSENTIALS 
Readmisson: 
Readmission for any reason within 30 days of the principle procedure? å¨ YES å¨ NO If yes, date: _______/______/_______ 
Information Source (select one) å¨ Medical Record å¨ Patient/Family Report å¨ Other 
Was this readmission unplanned at the time of the principle procedure? å¨ YES å¨ NO 
Select the primary reason for the unplanned readmission from the postoperative occurrences: 
Superficial SSI Pulmonary Embolism Coma > 24 hours Deep Vein Thrombosis (DVT) 
Deep SSI On ventilator > 48 hours Peripheral Nerve Injury Sepsis 
Organ / Space SSI Progressive Renal Insufficiency Cardiac Arrest req CPR 
Wound Disruption Acute Renal Failure Myocardial Infarction 
Pneumonia Urinary Tract Infection (UTI) Bleeding Requiring Transfusion Other: ICD-9 code______________ 
Unplanned Intubation Stroke / CVA Graft / Prosthesis / Flap Failure 
Notes ~ If ICD-9 is unknown, describe the reason. 
Was this readmission for a post operative occurrence likely related to the principle surgical procedure? å¨ YES å¨ NO 
Still in hospital > 30 days: å¨ YES å¨ NO 
Hospital Discharge Date: _____/_____/_______ (mm/dd/yyy) 
Postoperative Death: 
Postop Death w/in 30 days: å¨ YES å¨ NO Postop Death > 30 days: 
(if remained in acute care) 
å¨ YES å¨ NO 
Date of death: _____/_____/______ å¨ U n known Date of death: ______/______/_____ å¨ Unknown 
Unplanned Reoperation: 
Unplanned return to the operating room for a surgical procedure w/in 30 day postoperative period? å¨ YES å¨ NO 
Was the return to the OR for a postop occurrence likely related to the principle procedure, or to any additional surgery performed under the same 
anesthetic as the principle procedure? å¨ YES å¨ NO 
If yes, Surgery Date _____/_____/_______ CPT code ______________ ICD9 code ______________ 
Source (select one) å¨ Medical Record å¨ Patient/Family Report å¨ Other 
Notes ~ If CPT code is not documented, describe the surgery. 
Was there a SECOND unplanned reoperation within 30 days? å¨ YES å¨ NO 
Was the second return to the OR for a postoperative occurrence that was likely related to the principle procedure, or to any additional surgery (i.e., 
‘other’ or ‘concurrent’) performed under the same anesthetic as the principle procedure? å¨ YES å¨ NO 
If yes: Surgery Date _____/_____/_______ CPT code ______________ ICD9 code ______________ 
Source (select one) å¨ Medical Record å¨ Patient/Family Report å¨ Other 
Notes ~ If CPT code is not documented, describe the surgery. 
Were there more than two unplanned reoperations for an adverse outcome related to the principal surgery within 30 days? 






























D24 Office, Groote Schuur Hospital
Observatory 7925
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University of Cape Town
Dear Dr Spence
RE: Project 2017/061
PROJECT TITLE: Novel Approaches To Global Benchmarking Of Risk-Adjusted Surgical Outcomes
The above proposal has been reviewed by the Department of Surgery Research Committee. I am
pleased to inform you that the committee approved the scientific merit of the study, and endorse
the protocol for submission to the relevant ethics committee.
Please use the above project number in all future correspondence. 









To: spnric004@myuct.ac.za, rts25@mgh.harvard.edu 
CC:  
Subject: World Journal of Surgery - Decision on Manuscript ID WJS-17-02-0186 (D-RW-03) 
Body: 08-Apr-2017  
 
Dear Dr. Spence:  
 
Manuscript ID WJS-17-02-0186 entitled "Derivation, Validation and Application of a Low to middle 
Income Countries Specific Index to Predict Outcome Following Noncardiac Surgery" which you 
submitted to the World Journal of Surgery, has been reviewed.  The comments of the reviewer(s) are 
included at the bottom of this letter.  
 
The reviewers showed considerable interest in your manuscript but do not feel that it is acceptable for 
publication in its present form.  We would be ready to consider a revised version if you are able to 
completely and satisfactorily answer their questions and revise the manuscript to address each 
point.   The editors of the World Journal of Surgery reserve the right to reject a future revision of this 
manuscript if you fail to adequately address the reviewer's comments.  
 
To revise your manuscript, log into https://mc.manuscriptcentral.com/wjs and enter your Author 
Center, where you will find your manuscript title listed under "Manuscripts with Decisions."  Under 
"Actions," click on "Create a Revision."  Your manuscript number has been appended to denote a 
revision.  
 
You will be unable to make your revisions on the originally submitted version of the 
manuscript.  Instead, revise your manuscript using a word processing program and save it on your 
computer.  Please also highlight the changes to your manuscript within the document by using the 
track changes mode in MS Word or by using bold or colored text.  Once the revised manuscript is 
prepared, you can upload it and submit it through your Author Center.  
 
When submitting your revised manuscript, please respond to the comments made by the reviewer(s) in 
the space provided.  You can use this space to document any changes you make to the original 
manuscript.  In order to expedite the processing of the revised manuscript, please be as specific as 
possible in your response to the reviewer(s).  
 
IMPORTANT:  Your original files are available to you when you upload your revised manuscript.  Please 
delete any redundant files before completing the submission.  
 
Because we are trying to facilitate timely publication of manuscripts submitted to the World Journal of 
Surgery, your revised manuscript should be uploaded as soon as possible.  If it is not possible for you 
to submit your revision in a reasonable amount of time, we may have to consider your paper as a new 
submission.  
 
Once again, thank you for submitting your manuscript to the World Journal of Surgery and I look 
forward to receiving your revision.  
 
With kind regards,  
Dr. John Hunter  
Editor-in-Chief, World Journal of Surgery  
hunterj@ohsu.edu  
 
Reviewer(s)' Comments to Author:  
Reviewer: 1  
 
Comments to the Author  
Dear Colleagues  
 
Thank you for the opportunity to review the paper; ‘Derivation, Validation and Application of a Low to 
middle Income Countries Specific Index to Predict Outcome Following Noncardiac Surgery’. This is a 
paper describing the development of a simple, feasible and pragmatic risk stratification tool, which is 
proposed for noncardiac surgical patients in low and middle income countries.  
 
General comments:  
1. I particularly like the approach of only including risk factors which are feasible to collect i.e. >90% 
compliance. This is a strength of this approach to development of a preoperative risk model.  
2. It is claimed that this is a model for low to middle income countries (LMIC). The model was however 
developed in an upper middle income country (South Africa), and hence it may not be as robust in a 
low-income country (LIC). This should be acknowledged in the limitations section in the discussion. The 
risk factor which particularly concerns me in a low-income country would be the preoperative 
transfusion, which may not always be possible in a very resource limited environment. It is possible 
another risk factor which may reflect the need for preoperative transfusion may need to be substituted 
in a low-income country model. All references to LMIC should be replaced by MIC. In the discussion, it 
should be suggested that the model may have applicability in LIC, but this would need to be tested and 
externally validated.  
3. This is a model for general and vascular surgery only. This should be reflected in the title and the 
abstract. To claim, that this is a model for noncardiac surgery, it is important to externally validate the 
model in a broader noncardiac surgery population. Indeed, this would also need consideration of other 
non-vascular, non-general surgical procedures, which may need to be added to the model due to their 
impact on perioperative outcomes.  
Specific comments:  
1. Title and abstract:  
a. Should only claim MIC, and general and vascular surgery.  
2. Introduction:  
a. Please add preoperative to ‘application’; ‘The Surgical Apgar Score has been well  
validated globally but is based on data collected intraoperatively at 5-minute intervals, limiting its 
application’, as your paper is about a pragmatic preoperative score.  
3. Methods:  
a. The fact that the data collection was limited to general surgical and vascular surgical patients, does 
potentially limit the applicability of the score. This should also be acknowledged in a limitations section 
in the discussion.  
b. The data collection tool from the ACS website, should be added as web supplementary material for 
this paper, as should the REDCap data collection tool. This will help readers/ investigators who may 
want to externally validate this score in the future, in their own surgical settings.  
c. ‘postoperative’ should not be hyphenated.  
d. Step 2. The in-hospital mortality was 24 patients and for morbidity it was 127 for South Africa. Step 
two is unclear to me. Did you only include risk factors with a p<0.1 for SA mortality, in developing the 
model for the combined outcome of mortality and any morbidity (n=127)? If this is the case ideally one 
would not want to include more than about 13 variables in the logistic regression (events per variable 
(EPV) of 10).(1) You have 23 variables in Table 1, and 23 variables in the full model in table 3. Please 
make it clear to the readers which variables were entered into the logistic regression model, in what 
order they were entered and why that particular order of entry, so that the reader can understand the 
EPV in your multivariate analysis. At present, it appears that following the entry of the surgical 
procedure, various combinations of entries were conducted, which will result in an overfitted model.(2)  
e. Step 3. It is unclear to me, whether the derivation and validation cohort of the NSQIP database only 
included surgical procedures considered general surgical and/ or vascular procedures, or did the NSQIP 
cohort also include other non vascular, non general surgical procedures? It is unclear if the ‘thoracic’ 
procedures, where ‘thoracic’ procedures performed routinely by ‘general surgeons’ or ‘thoracic 
surgeons’. This needs to be clarified.  
f. Step 3. I would prefer the term ‘ROC curve’ as opposed to ‘ROC’ alone.  
g. Step 3. When discussing the performance of the ROC curve, it is not the ROC, but rather the AUC 
(area under the curve), which is presented as the c-statistic. So it would be better to read ‘highest c-
statistic’ as opposed to ‘highest ROC’. This is seen a few times in varying places in the text. These all 
need to be corrected e.g. had an ROC of 0.8672, should read;  had a c-statistic of 0.8672’.  
h. Step 3. Spelling ‘individually’  
i. Step 4. Please clarify if ‘any morbidity’ includes mortality.  
j. Step 4. For future reference the ‘Hosmer-Lemeshow test’ for calibration is not ideal for assessing 
calibration.2 It is most likely to be of very limited value in your South African cohort with a small 
sample size.  
4. Results:  
a. The following statement is problematic, and I cannot agree with it; ‘patients in the SA dataset 
appeared to be sicker with a higher proportion of emergency cases, diabetics, symptomatic dyspnea, 
functional dependency, congestive heart failure, chronic obstructive pulmonary disease, acute renal 
failure, disseminated cancer and preoperative sepsis’.  
Firstly, it is well documented that significantly more South African patients (3) have a lower ASA score 
than patients in high-income countries,4 which is consistent with your data. Furthermore, ASA is robust 
predictor of perioperative outcome)(4) despite some subjectivity to its assessment. (There are 
techniques/ mechanisms to improve the reliability of the documentation of the ASA score, but I believe 
this is beyond the scope of your paper, and will detract from the more important aspect of your risk 
prediction model).  
Secondly, you may be mixing other risk factors which do not necessarily change the ASA score e.g. 
urgent and emergent surgery (which is significantly more common in your cohort than the NSQIP 
cohort). Urgent and emergent surgery may result in more symptomatic patients from the surgical 
pathology e.g. associated dyspnoea, acute renal failure and sepsis.  
Thirdly, the absolute number of patients with some of the pathologies you describe, are still far smaller 
than the number of patients who are ASA 3 or above. What you are essentially describing is a result of 
i) a single tertiary centre compared to data from a range of levels of care, and ii) a health system 
which is characterised by late surgical presentation,(3) compared to a more functional high-income 
country health system with early presentation of surgical pathologies.  
b. There is a selection bias in the South African cohort which has resulted in the higher proportion of 
certain types of operative procedures. This is a function of a single, tertiary centre as the only site for 
data capture.  
c. ICU admission. This is a post hoc analysis of the Codman Score associated with ICU admission. I 
have reservations of its applicability, as it reflects the admissions to ICU at a single hospital, which may 
be variously affected by bed availability, prognosis of patient, etc. I would remove this from the results. 
If one, wanted to know the use of the Codman Score for predicting ICU admission, it would be better to 
study this prospectively, where the need for ICU was determined (irrespectively of whether the patient 
received ICU admission), and then this is correlated with the Codman Score.  
5. Discussion:  
a. I would suggest rewriting the discussion as suggested by Docherty and Smith,(5) as at present I 
believe the discussion does not explicitly address the strengths, limitations and implications of the 
research, and as such the emphasis of the discussion is too focused on a small part of the entire 
research project i.e. in particular O/E ratio, and ASA score, which does not do justice to the important 
research presented in the paper. Based on Docherty and Smith’s proposal this is what I would 
suggest;  
i. Statement of principal findings: Feasible, 7 variable model for general and vascular surgery in a MIC.  
ii. Strengths and weaknesses of the study: Strengths; feasible, and simple. Weaknesses, single tertiary 
centre, limited to general and vascular surgery from a MIC, and not a LIC. Statistical weaknesses, 
possibly overfitted model.  
iii. Strengths and weaknesses in relation to other studies, discussing particularly any differences in 
results: Strengths, simple parsimonious model when compared to NSQIP.  
iv. Meaning of the study, possible mechanisms and implications for clinicians or policymakers: If the 
model could be externally validated, it is simple enough that an expected outcome for a country could 
be obtained of a period of time, after which the O/E ratio, may be useful for benchmarking 
performance within a country.  
v. Unanswered questions and future research: This is a model which may be feasible in LIC. It is 
necessary however, that there is external validation of the model in LIC. Furthermore, to extend the 
model beyond general and vascular surgery, it will need possible inclusion of other surgical procedures 
into the model.  
b. Other comments; Remove LMIC and replace with MIC.  
c. Statement; ‘In contrast, our findings question the reliability of ASA rating in such diverse settings.’ I 
cannot agree with this from a small single centre study, particularly when 28 countries of over 46 000 
patients have shown its reliability,4 and 50 centres in South Africa have shown its reliability.(2) This is 
discussed above, and should be removed. I believe the inappropriate focus on the ASA score is 
detracting from the more important contribution your model could make to surgical outcomes, and in 
all likelihood, the ASA score will always be one of the included risk factors in your model.  
6. References:  
a. Please complete reference 13.  
7. Tables  
a. Table 2. Please clarify if ‘any morbidity’ includes mortality  
b. Table 3. I would remove ‘model with 23 variables’. This is an overfitted model, based on your 
sample size, and hence should not be included in the table.  
8. Figures  
a. Figure 3.  
i. Spelling ‘cumulative’  
ii. CI for the outcomes would be desirable. I expect that there is a lot of overlap between scores. It 
may be more advantageous to have two or three score categories, where there is little overlap of CI for 
outcomes.  
 
Thank you for the opportunity to review this paper.  
 
Regards  
Bruce Biccard  
 
Conflict of interest: I am an author and co-investigator in the SASOS paper which I reference in some 
of my discussions of this manuscript above.  
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Reviewer: 2  
 
Comments to the Author  
This is an important manuscript that moves forward the field of global surgery. A hearty 
congratulations to the team for taking on this task, and cleverly so. The Lancet Commission 
championed the need for benchmarks and standards -- for indicators of the strength of the surgical 
system and was met with widespread acceptance on the indisputable assertion. It did not, however, 
prescribe a specific approach to how make sense of indicators collected in widely different health 
systems with different patient populations. The work by Spence and team moves us closer to 
understanding how to measure health system quality and strength. It also provides a valuable tool for 
surgeons operating in the trenches-- perhaps for the first time ever -- to benchmark their outcomes 
against their peers in other parts of the world. Clearly, the Codman score, as described, will still has 
many years of work ahead to tweak and revise based on its performance in different environments, 
and perhaps even further simplification and less reliance on subjective assessments like ASA. 
Nonetheless, it provides a valuable first step based on existing and accepted measurements systems 
for quality, consistent with calls from works before it (e.g. The Lancet Commission), and simplifies and 
adjusts it to being able to be collected in the low-resource environment.  
 
My one point of contention with the framing of the manuscript, however, is that this really has to do 
with simplifying NSQIP to be able to be collected with fever variables than the data and time-intensive 
manner it currently requires. It could be used in Boston just as well as in Cape Town. And while it is 
true that the data simplification makes it more reasonable to be used in an LMIC, it is not actually 
developed or tested in a true "low-resource" environment. Instead the score is developed and tested in 
a South African hospital that, true, is in an "LMIC" (a horrible catch-all phase to begin with) but 
wouldn't fit my definition of a 'low-resource' setting.  
 
The authors peripherally discuss this in the limitations section, and I understand the reality of the 
logistical/financial limitations of testing this in multiple environments around the world.  
But the absence of testing in some of the lowest-resource environments presents real challenges to the 
Codman score's applicability to these settings.  
 
For example, usage of the blood transfusion requirement of 4 units or greater in the score predicates 
that we are operating in environments where blood transfusion/blood banking is an option. This limits 
the applicability of this score away from broad swaths of the world. This is unfortunate, because the 
rest of the score is easily collectible. Can the authors comment on whether a modification can be 
introduced that is based on a starting Hemoglobin (this is also a challenge, granted, but at least 
provides an objective measure and is more broadly available in low-resource hospitals in rural settings 
than a the scarce resource of blood). 
Date Sent: 08-Apr-2017  
 
From: worldjsurg@ohsu.edu 
To: spnric004@myuct.ac.za, rts25@mgh.harvard.edu 
CC:  
Subject: World Journal of Surgery - Decision on Manuscript ID WJS-17-02-0186.R1 (D-RW-02) 
Body: 18-Jun-2017  
 
Dear Dr. Spence:  
 
Manuscript ID WJS-17-02-0186.R1 entitled "Derivation, Validation and Application of A Pragmatic 
Risk Prediction Index for Benchmarking of Surgical Outcomes" which you submitted to the World 
Journal of Surgery, has been reviewed.  The comments of the reviewer(s) are included at the bottom 
of this letter.  
 
The reviewer(s) suggest some minor revisions to your manuscript.  Therefore, I invite you to respond 
to the reviewer(s)' comments and revise your manuscript.  
 
To revise your manuscript, log into https://mc.manuscriptcentral.com/wjs and enter your Author 
Center, where you will find your manuscript title listed under "Manuscripts with Decisions."  Under 
"Actions," click on "Create a Revision."  Your manuscript number has been appended to denote a 
revision.  
 
You will be unable to make your revisions on the originally submitted version of the 
manuscript.  Instead, revise your manuscript using a word processing program and save it on your 
computer.  Please also highlight the changes to your manuscript within the document by using the 
track changes mode in MS Word or by using bold or colored text.  
 
Once the revised manuscript is prepared, you can upload it and submit it through your Author 
Center.  
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Date Sent: 07-Jul-2017  
 
 
I have a few minor revisions; (I have used the review pdf page and line numbers).  
 
1. Page 8, line 13: Remove text 'The tertiary outcome collected in the SA dataset was post-operative 
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Editor-in-Chief, World Journal of Surgery  
hunterj@ohsu.edu 
Date Sent: 07-Jul-2017  
